Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Growth Factor Antagonists
Witt, Daniel P.
Repligen Corporation, Waltham, MA, United States
Search 3 grants from Daniel Witt
Search grants from Repligen Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Protection &Advocacy for Individuals with Mntl Illness
Non-Invasive Measurements of Brown Adipose Tissues
Lithium Effects on Tetrahydrobiopterin Deficit in GHC1-Associated Bipolar Disorde
Fatty Acid Oxidation in Isolated Perfused Mouse Heart
Early Experience and Neurodegeneration
Recently added grants:
Reward processing and depressive subtypes: Identifying neural biotypes related to suicide risk, resilience, and treatment response
HPV alternative splicing in cervical cancer radiation response
Non-invasive, Transgene-free, on-demand Pharmacological Modulation of Neural Activity
Cholinergic Receptors in Aging and Early Alzheimer's Disease: Longitudinal Change
Impact of COPD on Lung-Resident MAIT Cell Frequency, Function and Recognition of Bacterial Infection
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
7R43EY011333-02
Application #
2020035
Study Section
Special Emphasis Panel (ZRG1-VISA (02))
Project Start
1996-03-16
Project End
1997-02-06
Budget Start
1996-03-16
Budget End
1997-02-06
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Repligen Corporation
Department
Type
DUNS #
City
Waltham
State
MA
Country
United States
Zip Code
02453
Comments
Be the first to comment on Daniel Witt's grant